Biotechnology Stocks II Performance Guide: Monte Rosa Therapeutics, Inc. (GLUE)
GLUE has no dividends.
Table and Chart of GLUE Performance
See what a $1,000 investment in GLUE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GLUE Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $24.52 |
| End Date | May-16-2024 |
| End Price | $5.22 |
| # Prices | 35 |
| Min Date | Nov-30-2023 |
| Min Price | $3.10 |
| Max Date | Aug-31-2021 |
| Max Price | $35.69 |
| Total Return | -78.71% |
| Annualized Return | -41.16% |
| Current Value of $1,000 Purchase | $213 |
| Number Returns | 595 |
| Average Return | -36.15% |
| Number Profitable Returns | 65 |
| Percent Profitable Returns | 10.92% |
| Number Unprofitable Returns | 530 |
| Percent Unprofitable Returns | 89.08% |
| Profitable to Unprofitable Returns Ratio | 0.12 |
| GLUE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $264,178,000 |
| Beta | 1.538 | Price to Sales |
| Earnings per Share | $-2.5100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.015 |
| PRICE DATA | |
| 52 Week High | $8.84 |
| 52 Week Low | $2.44 |
| Analyst Target Price | $16.5 |
| 50-Day Moving Average | $6.29 |
| 200-Day Moving Average | $5.38 |
| FINANCIAL DATA | |
| Revenue per Share | $0.02 |
| Revenue | $1,064,000 |
| Profit Margin | 0% |
| Return on Equity | -68.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GLUE Compare Returns with S&P 500
GLUE Trendline Chart
GLUE Moving Average Chart
GLUE Stock Return Map - See Patterns of Gains and Losses
GLUE Stock Returns/Purchase Dates